CRMD FY 2017 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena

CRMDCorMedix Inc.

$518M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$329,327+47.0% YoY

Gross Profit

$214,36365.1% margin

Operating Income

-$33M-9997.4% margin

Net Income

-$33M-10023.4% margin

EPS (Diluted)

$-2.99

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$29M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$13M

Total Liabilities

$6M

Stockholders' Equity

-$152M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$329,327	$224,105	+47.0%
Gross Profit	$214,363	-$142,568	+250.4%
Operating Income	-$33M	-$25M	-33.0%
Net Income	-$33M	-$25M	-33.9%